SenesTech FY2022 product sales break $1M, up 77% YoY; net loss $9.7M

SenesTech, Inc.

Product sales $1.0M in 2022, up 77% vs 2021; e-commerce was 46% of sales.
Net loss $9.7M in 2022 vs $8.3M in 2021; Q4 net loss $2.1M.
Adjusted EBITDA loss $8.5M in 2022 vs $7.8M in 2021; Q4 loss $1.6M.
Cash $4.8M at Dec 31, 2022.
CEO Joel Fruendt appointed Nov 2022; sales force expanded to 7 reps.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SenesTech, Inc. reported the fourth quarter and fiscal year ended December 31, 2022 results: revenue $1.0 million, net income $9.7 million.

Period: the fourth quarter and fiscal year ended December 31, 2022
Revenue: $1.0 million
Net income: $9.7 million
Result: reported results

Exact text from the filing

, although we reserve the right to discontinue the availability at any time. --- EX-99.1 (EX-99.1) --- SenesTech Announces 2022 Financial Results Product Sales Break $1 Million Sales Increase 77% for the Year PHOENIX, Ariz., March 16, 2023. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), ( www.senestech.com ) the rodent fertility control

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

SenesTech, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-008298

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.